UNH

UnitedHealth Group Inc. (UNH) - 2024 Annual Report Summary

Business Context and Reporting Period

This summary covers the Form 10-K for UnitedHealth Group Incorporated for the fiscal year ended December 31, 2024. UnitedHealth Group operates two primary businesses: UnitedHealthcare (health benefits) and Optum (health services, data, and pharmacy). The company serves approximately 50.7 million people through its UnitedHealthcare segment and 100 million consumers through Optum Health. The reporting period was significantly impacted by a major cyberattack on its Change Healthcare subsidiary in February 2024 and the strategic divestiture of its South American operations.

Key Financial Metrics

Material Changes vs. Prior Period

• Significant One-Time Losses: Net earnings declined sharply due to an $8.3 billion loss recorded on the sale of the Brazil operations and the reclassification of remaining South American operations as "held for sale." This included $4.1 billion in cumulative foreign currency translation losses.
• Cyberattack Impact: The February 2024 cyberattack on Change Healthcare resulted in $2.2 billion in direct response costs (including $9 billion in interest-free loans to providers) and $867 million in estimated business disruption impacts (lost revenue) for Optum Insight. Additionally, medical costs increased by approximately $640 million due to the temporary suspension of care management activities.
• Medical Cost Trends: The Medical Care Ratio (MCR) increased to 85.5% from 83.2%. This was driven by Medicare Advantage funding reductions, a timing mismatch in Medicaid redeterminations, increased hospital coding intensity, and higher specialty drug costs.
• Segment Performance:
  • UnitedHealthcare: Revenues grew 6% to $298.2 billion, but operating earnings declined 5% to $15.6 billion due to funding pressures and cyberattack costs.
  • Optum: Revenues grew 12% to $253.0 billion. Optum Health earnings grew 18%, and Optum Rx earnings grew 14%. Optum Insight earnings declined 27% primarily due to the cyberattack disruption.

Guidance, Outlook, and Risks

• Outlook: Management expects to continue incurring direct response costs and business disruption impacts in 2025, though at a lesser extent as transaction volumes normalize. The company anticipates continued pressure on Medicare Advantage funding and Medicaid margins.
• Capital Allocation: The company returned significant capital to shareholders, including $9.0 billion in share repurchases and $7.5 billion in dividends. The quarterly dividend was increased to an annual rate of $8.40 per share. As of year-end, $33 million shares remained authorized for repurchase.
• Key Risks:
  • Cybersecurity: Ongoing risks related to the Change Healthcare incident, including potential litigation, regulatory actions, and reputational harm.
  • Regulatory Environment: Continued pressure on Medicare Advantage benchmarks and risk adjustment models; potential changes to Medicaid reimbursement rates.
  • Medical Cost Inflation: Rising costs for specialty pharmaceuticals and increased care utilization patterns.

Investor Verification Checklist

• Verify the composition of the $8.3 billion loss on the sale of South American operations to understand the portion attributable to foreign currency translation versus operational impairment.
• Monitor the recovery of Optum Insight revenues and the timeline for full restoration of Change Healthcare transaction volumes to pre-attack levels.
• Assess the sustainability of the Medical Care Ratio (MCR) given the headwinds from Medicare funding reductions and Medicaid redeterminations.
• Review the status of pending acquisitions (approximately $4 billion in anticipated capital) and their potential impact on future earnings.
• Track the resolution of legal and regulatory matters related to the cyberattack and ongoing government audits of risk adjustment data.